🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
04/09/1996 0,1908 USD
06/06/1996 0,1622 USD
06/03/1996 0,1622 USD
06/12/1995 0,1622 USD
05/09/1995 0,1622 USD
02/06/1995 0,1431 USD
03/03/1995 0,1431 USD
02/12/1994 0,1431 USD
02/09/1994 0,1431 USD
02/06/1994 0,1336 USD
02/03/1994 0,1336 USD
02/12/1993 0,1336 USD
02/09/1993 0,1336 USD
02/06/1993 0,1193 USD
02/03/1993 0,1193 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/08/1979 1,86 1,87 1,85 1,86 +0,36% 0,89% 1.561.939
28/08/1979 1,85 1,86 1,85 1,86 +0,36% 0,71% 1.652.486
27/08/1979 1,84 1,87 1,83 1,85 +0,36% 2,34% 2.501.366
24/08/1979 1,85 1,85 1,84 1,84 -0,72% 0,90% 1.384.618
23/08/1979 1,88 1,88 1,86 1,86 -1,23% 1,06% 1.678.896
22/08/1979 1,89 1,89 1,87 1,88 -0,52% 1,05% 1.592.122
21/08/1979 1,89 1,89 1,87 1,89 +0,18% 1,06% 1.105.430
20/08/1979 1,89 1,90 1,88 1,89 +0,00% 1,05% 3.437.021
17/08/1979 1,88 1,89 1,87 1,89 +0,18% 1,23% 2.225.952
16/08/1979 1,88 1,90 1,88 1,88 +0,71% 1,06% 7.941.744
15/08/1979 1,83 1,87 1,83 1,87 +1,99% 2,17% 3.282.336
14/08/1979 1,83 1,84 1,82 1,83 +0,36% 0,72% 2.293.862
13/08/1979 1,79 1,83 1,79 1,83 +2,23% 1,85% 5.183.827
10/08/1979 1,79 1,80 1,78 1,79 -0,18% 1,30% 3.459.658
09/08/1979 1,79 1,80 1,78 1,79 +0,00% 0,92% 2.950.330
08/08/1979 1,77 1,79 1,77 1,79 +1,12% 1,12% 2.908.829
07/08/1979 1,75 1,78 1,75 1,77 +1,13% 1,51% 5.708.246
06/08/1979 1,74 1,75 1,73 1,75 +0,77% 0,96% 2.086.358
03/08/1979 1,76 1,77 1,74 1,74 -1,32% 1,69% 1.750.579
02/08/1979 1,77 1,78 1,75 1,76 -0,37% 1,87% 2.135.405
01/08/1979 1,76 1,77 1,74 1,77 +0,56% 1,51% 2.108.995
31/07/1979 1,76 1,77 1,75 1,76 +0,00% 0,94% 1.592.122
30/07/1979 1,76 1,77 1,75 1,76 +0,00% 1,13% 1.531.757
27/07/1979 1,77 1,77 1,74 1,76 -1,67% 1,31% 1.671.350
26/07/1979 1,77 1,79 1,76 1,79 +0,94% 1,50% 2.256.134
25/07/1979 1,75 1,77 1,74 1,77 +1,32% 1,52% 1.701.533
24/07/1979 1,75 1,75 1,74 1,75 +0,00% 0,76% 1.260.115
23/07/1979 1,76 1,76 1,74 1,75 -0,94% 1,50% 1.361.981
20/07/1979 1,75 1,77 1,75 1,76 +0,56% 1,14% 1.218.614
19/07/1979 1,77 1,78 1,74 1,75 -0,93% 2,62% 5.263.056